Posted in | News | Nanobusiness

Finland and Russia to Cooperate in Nanotechnology Investment

Government-owned investment company Suomen Teollisuussijoitus Oy (Finnish Industry Investment Ltd) and Russian Corporation of Nanotechnologies (RUSNANO) on Thursday signed an agreement on a Finno-Russian nanotechnology investment programme.

The aim of the cooperation is to co-invest a total of MEUR 50 in rapidly growing and internationalising nanotechnology companies operating in both Finland and Russia. Finnish Industry Investment and RUSNANO are evaluating possible target companies and will invest in them jointly and on equal terms. The investment programme will last three years.

"We believe that combining top-level Finnish knowhow with top-level Russian expertise will produce technology that is globally competitive," comments Industry Investment's President & CEO, Juha Marjosola.

"Drawing on both RUSNANO's and Industry Investment's solid experience, we have together reviewed the deal flow and identified a number of interesting companies. The first joint investment can be implemented within six months."

"This co-investment programme will allow us to consolidate our resources and experience in developing innovative companies, thus opening new opportunities for Russian technologies to enter global markets," says RUSNANO's CEO Anatoly Chubais.

Finland's Prime Minister Matti Vanhanen, Russia's Prime Minister Vladimir Putin and Finland's Minister of Economic Affairs Mauri Pekkarinen attended the signing of the cooperation agreement on nanotechnology investment at the 1st EU-Russia Innovation Forum, which was held in the Finnish city of Lappeenranta.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.